Back to Research Hub
Amneal Pharmaceuticals, Inc.
AMRX
$17.75-0.35 (-1.93%)
Amneal Pharmaceuticals, Inc., operating alongside its various subsidiaries, is a diversified pharmaceutical company involved in the development, acquisition of licenses, manufacturing, marketing, and distribution of both generic and specialized medicinal products.
StreetsValue research for Amneal Pharmaceuticals, Inc. (AMRX)
Members get the full report for Amneal Pharmaceuticals, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.